Coherus Biosciences | CHRS - Trade Creditors


Coherus Biosciences reported $9.91M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
Akebia Therapeutics USD 8.39M 12.8M Mar/2026
ALKERMES USD 102.36M 5.59M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
Amarin USD 48.15M 2.8M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Baxter International USD 1.09B 87M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Fujifilm JPY 292.7B 15.36B Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
Merck USD 3.86B 541M Mar/2026
Myriad Genetics USD 32.6M 2.6M Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
PTC Therapeutics USD 25.48M 20M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Xencor USD 7.92M 2.91M Mar/2026
Zoetis USD 507M 20M Mar/2026